Clinical Trial Update: Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer [NA]

View source ↗

Summary

This clinical trial evaluating hypofractionated intensity-modulated radiation therapy plus hormonal therapy in high-risk prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sergio Faria | Conditions: High Risk Prostate Cancer | NA | Status: COMPLETED